Literature DB >> 15888782

Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn.

G Kristjánsson1, M Högman, P Venge, R Hällgren.   

Abstract

BACKGROUND AND AIMS: To elucidate the dynamics of nitric oxide (NO) production induced by rectal gluten challenge and the relation between NO production and mucosal granulocyte activation. SUBJECTS AND METHODS: Release of rectal NO was measured in 13 patients with coeliac disease and in 18 controls before and after rectal wheat gluten challenge. Rectal gas was collected with a rectal balloon using a newly developed instrument/technique, the "mucosal patch technique". The instrument allows simultaneous measurements of concentrations of granulocyte mediators in the rectal mucosa. We measured myeloperoxidase (MPO), eosinophil cationic protein (ECP), and histamine. For comparison, we made similar measurements after corn (maize) gluten challenge.
RESULTS: In all coeliac patients rectal NO concentration increased after gluten challenge and reached a peak after 15 hours (mean 9464 (SEM 2393) parts per billion (ppb); range 250-24982). The maximum MPO and ECP increase occurred five hours after challenge. A correlation was found between mucosal MPO and NO production at 15 hours. Six of the patients showed an increase in NO production 15 hours after rectal corn gluten challenge but this was much smaller than after gluten challenge. No increases were seen in the control group after either challenge.
CONCLUSION: Mucosal activation of neutrophils and eosinophils precedes pronounced enhancement of mucosal NO production after rectal wheat gluten challenge in patients with coeliac disease. Some of our coeliac patients displayed signs of an inflammatory reaction, as measured by NO and granulocyte markers, after rectal corn gluten challenge.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888782      PMCID: PMC1774524          DOI: 10.1136/gut.2004.057174

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  41 in total

1.  Increased luminal nitric oxide concentrations in the small intestine of patients with coeliac disease.

Authors:  B Everts; P Stotzer; M Olsson; A Kilander; A Pettersson
Journal:  Eur J Clin Invest       Date:  1999-08       Impact factor: 4.686

2.  Local challenge of oral mucosa with gliadin in patients with coeliac disease.

Authors:  H Lähteenoja; M Mäki; M Viander; A Toivanen; S Syrjänen
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

Review 3.  The role of nitric oxide in inflammation and immunity.

Authors:  R M Clancy; A R Amin; S B Abramson
Journal:  Arthritis Rheum       Date:  1998-07

4.  Dietary analysis in symptomatic patients with coeliac disease on a gluten-free diet: the role of trace amounts of gluten and non-gluten food intolerances.

Authors:  K B Faulkner-Hogg; W S Selby; R H Loblay
Journal:  Scand J Gastroenterol       Date:  1999-08       Impact factor: 2.423

5.  Neutrophilic inflammation in severe persistent asthma.

Authors:  A Jatakanon; C Uasuf; W Maziak; S Lim; K F Chung; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

6.  Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma.

Authors:  S Lim; A Jatakanon; S Meah; T Oates; K F Chung; P J Barnes
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

7.  Increased luminal nitric oxide in inflammatory bowel disease as shown with a novel minimally invasive method.

Authors:  M Herulf; T Ljung; P M Hellström; E Weitzberg; J O Lundberg
Journal:  Scand J Gastroenterol       Date:  1998-02       Impact factor: 2.423

Review 8.  Current concepts of celiac disease pathogenesis.

Authors:  D Schuppan
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

9.  Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma.

Authors:  I Horváth; L E Donnelly; A Kiss; S A Kharitonov; S Lim; K F Chung; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1998-10       Impact factor: 21.405

10.  Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome.

Authors:  G Kristjánsson; P Venge; A Wanders; L Lööf; R Hällgren
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

View more
  10 in total

1.  The sourdough fermentation may enhance the recovery from intestinal inflammation of coeliac patients at the early stage of the gluten-free diet.

Authors:  Maria Calasso; Olimpia Vincentini; Francesco Valitutti; Cristina Felli; Marco Gobbetti; Raffaella Di Cagno
Journal:  Eur J Nutr       Date:  2012-02-04       Impact factor: 5.614

2.  Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease.

Authors:  Karen M Lammers; Sunaina Khandelwal; Fatima Chaudhry; Debby Kryszak; Elaine L Puppa; Vincenzo Casolaro; Alessio Fasano
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

3.  Maize prolamins resistant to peptic-tryptic digestion maintain immune-recognition by IgA from some celiac disease patients.

Authors:  Francisco Cabrera-Chávez; Stefania Iametti; Matteo Miriani; Ana M Calderón de la Barca; Gianfranco Mamone; Francesco Bonomi
Journal:  Plant Foods Hum Nutr       Date:  2012-03       Impact factor: 3.921

4.  Mucosal reactivity to cow's milk protein in coeliac disease.

Authors:  G Kristjánsson; P Venge; R Hällgren
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

5.  Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells.

Authors:  V De Re; M P Simula; L Caggiari; N Orzes; M Spina; A Da ponte; L De Appollonia; R Dolcetti; V Canzonieri; R Cannizzaro
Journal:  Clin Exp Immunol       Date:  2007-03-05       Impact factor: 4.330

6.  Gliadin Induces Neutrophil Migration via Engagement of the Formyl Peptide Receptor, FPR1.

Authors:  Karen M Lammers; Marcello Chieppa; Lunhua Liu; Song Liu; Tatsushi Omatsu; Mirkka Janka-Junttila; Vincenzo Casolaro; Hans-Christian Reinecker; Carole A Parent; Alessio Fasano
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

Review 7.  Maize prolamins could induce a gluten-like cellular immune response in some celiac disease patients.

Authors:  Juan P Ortiz-Sánchez; Francisco Cabrera-Chávez; Ana M Calderón de la Barca
Journal:  Nutrients       Date:  2013-10-21       Impact factor: 5.717

Review 8.  Navigating the Gluten-Free Boom: The Dark Side of Gluten Free Diet.

Authors:  Aaron Lerner; Thomas O'Bryan; Torsten Matthias
Journal:  Front Pediatr       Date:  2019-10-15       Impact factor: 3.418

9.  The Prevalence of Anti-Zein Antibodies: A Comparative Study between Celiac Disease and Irritable Bowel Syndrome.

Authors:  Luis Alberto Sánchez-Vargas; Karina Guadalupe Hernández-Flores; Francisco Javier Cabrera-Jorge; José María Remes-Troche; Job Reyes-Huerta; Héctor Vivanco-Cid
Journal:  Nutrients       Date:  2021-02-17       Impact factor: 5.717

10.  Cow's milk protein sensitivity assessed by the mucosal patch technique is related to irritable bowel syndrome in patients with primary Sjögren's syndrome.

Authors:  M Lidén; G Kristjánsson; S Valtysdottir; P Venge; R Hällgren
Journal:  Clin Exp Allergy       Date:  2008-06       Impact factor: 5.018

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.